太龙药业(600222.SH)：第三期员工持股计划所持有1084.61万股已全部出售完毕

Core Viewpoint - Tailong Pharmaceutical (600222.SH) announced the complete sale of 10.8461 million shares held under its third employee stock ownership plan as of the announcement date [1] Group 1 - The third employee stock ownership plan has successfully sold all shares it held [1] - The total number of shares sold amounts to 10.8461 million [1]